Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Artale, Salvatore
HERMIONE-7, NCT04227327: Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients	Active, not recruiting	2	31	Europe	Abemaciclib, Aromatase Inhibitors	University of Milano Bicocca	Advanced Breast Cancer	12/23	12/23
HERMIONE-13, NCT05173103: Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer	Recruiting	N/A	150	Europe		University of Milano Bicocca	Advanced Breast Cancer, Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer	01/24	01/24
MIC-1, NCT06794931: Study on the Impact of a Modified Mediterranean Diet, in Patients With Colorectal Cancer Undergoing Active Medical Oncology Treatment	Recruiting	N/A	40	Europe	Nutrition, Specific diet, Biological samples collection, Microbiota analyses	Azienda Socio Sanitaria della Brianza, University of Milano Bicocca	Undefined	07/28	07/28

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Artale, Salvatore
HERMIONE-7, NCT04227327: Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients	Active, not recruiting	2	31	Europe	Abemaciclib, Aromatase Inhibitors	University of Milano Bicocca	Advanced Breast Cancer	12/23	12/23
HERMIONE-13, NCT05173103: Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer	Recruiting	N/A	150	Europe		University of Milano Bicocca	Advanced Breast Cancer, Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer	01/24	01/24
MIC-1, NCT06794931: Study on the Impact of a Modified Mediterranean Diet, in Patients With Colorectal Cancer Undergoing Active Medical Oncology Treatment	Recruiting	N/A	40	Europe	Nutrition, Specific diet, Biological samples collection, Microbiota analyses	Azienda Socio Sanitaria della Brianza, University of Milano Bicocca	Undefined	07/28	07/28